Oryzon Genomics announces additions of Dr. Konstantinos Alataris, Dr. Pierre Beaurang, Dr. Montserrat Vendrell and Luis Sánchez Quintana to join its Board as Independent Directors
– SPAIN, Barcelona – Oryzon Genomics, S.A. (BME: ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, announced the additions of Dr.…